Skip to main content
. 2000 Nov;38(11):3926–3931. doi: 10.1128/jcm.38.11.3926-3931.2000

TABLE 2.

Results of oxacillin resistance phenotyping, susceptibility testing, coagulase gene RFLP by PCR, PFGE, and phage typing

Isolate Acquisition Ethnicity ORb phenotype Susceptibility toc:
RFLP type PFGE type Phage type at 100 × RTDd Experimental set
FD RD TC E CIP
F810539 Community Caucasian Heterogeneous S S S S S AI A0 29/52/52A/79/80/3A/42E/47/53/54/77/81/95 56A
D817541 Community Caucasian Heterogeneous S S S S S AI A0 29/52/52A/79/80/3A/3C/6/42E/47/53/54/77/84/81/94/95 56A
A830538 Community Caucasian Heterogeneous S S S S S AI A0 29/52/5A/79/80/3A/42E/47/53/54/77/81 56A
I825560 Community Polynesian Heterogeneous S S S S S AI A0 6/42E/47/53/54/77/81 MR12
B826559 Community Polynesian Heterogeneous S S S S S AII A0 29/80/42E/47/53/54/75/77/81 56A/67R/M5/F33/F38
I816601 Community Polynesian Heterogeneous S S S S S AI A0 29/52/52A/79/80/3A/6/42E/47/53/54/77/84/81/95 56A/MR12
H823537 Community Polynesian Heterogeneous S S S S S AI A0 29/52/52A/79/80/3A/6/42E/47/53/54/77/81/95 MR12
G823530 Community Polynesian Heterogeneous S S S S S AI A0 29/52/52A/80/3A/6/42E/47/53/54/77/81/95 47T/MR12
D828570 Community Polynesian Heterogeneous S S S S S AI A0 29/52/52A/80/3A/3C/47/53/54/77/95 Not typeable
A803355 Community Polynesian Heterogeneous S S S S S AI A0 29/52/52A/79/80/3A/42E/47/53/54/77/81/94 56A
A806533 Community Polynesian Heterogeneous S S S S S AI A0 29/52/52A/79/80/3A/3C/42E/47/53/54/77/81/94 56A
E803543 CommunityRa Polynesian Heterogeneous S S S S S AI A0 29/52/52A/80/3A/3C/6/42E/47/53/54/77/81/95 56A/1648/F38
E822547 CommunityR Polynesian Heterogeneous S S S S S AI A0 42E/47/54/77/81 56A
F809718 CommunityR Polynesian Heterogeneous S S S S S AI A0 6/42E/47/53/54/77/81 56A
F809715 CommunityR Polynesian Heterogeneous S S S S S AI A0 6/42E/47/53/54/75/77/84/81 56A/67R/87M/F38
A823547 Community Aboriginal Heterogeneous S S S S S AI A1 29/52/52A/79/80/3A/47/54/77/95 Not typeable
C810534 Community Caucasian Heterogeneous S S S S R AII A1 29/52/52A/79/80/3A/42E/54/77 F38
G821561 Community Polynesian Heterogeneous S S S S S AI A1 29/52/52A/80/3A/42E/47/54/77/84/95 56A/MR12
D821552 CommunityR Polynesian Heterogeneous S S S S S AI A2 29/52/52A/79/80/3A/3C/6/42E/47/53/54/77/81/94/95/96/88 56A/1648/F38
E802537 Community Polynesian Heterogeneous S S S S S AI A3 29/52/52A/79/80/3A/47/53/54/77 Not typeable
I802552 Hospital Polynesian Heterogeneous S S S S S AI A4 29/80/42E/54/81/95 MR12
E822485 Hospital Caucasian Homogeneous S S S R R D B 52/77/83A/95 Not typeable
J710566 Nursing home Caucasian Heterogeneous S S S S S AIV C 83A M5/F30/F38
F829549 CommunityR Caucasian Homogeneous S S S R S C D 6/47/53/54 56B/56C
C801535 Hospital Caucasian Homogeneous S S S S S C D 29/52/52A/79/80/6/47/53/54/95 56B/56C/M3/M5/F33/F38
D828354 Hospital Caucasian Heterogeneous R S R S S BII E 83A Not typeable
B827549 Nursing home Caucasian Heterogeneous R S R S S BI E 52A/42E/53/54/83A MR25
I823541 Hospital Caucasian Homogeneous S S R R S AI G2 83A/85/88 47T/90A/87M/MR12/MR25
E804531 Hospital Caucasian Heterogeneous S S S S S AIII I 53/81 56A/67R/M3
E812560 Hospital Caucasian Homogeneous S S R R S AI J Not typeable 47T/56A/1648/F38/MR25
D808118 Hospital Caucasian Heterogeneous R S S S S BI L 42E/47/53/54/83A/85 56B/56C/F38/MR25
a

CommunityR, community acquired with risk factors. 

b

OR, oxacillin resistance. 

c

S, susceptible; R, resistant. FD, fusidic acid; RD, rifampin; TC, tetracycline; E, erythromycin; CIP, ciprofloxacin. 

d

RTD, routine test dilution.